Peripheral Arterial Disease Trial, Recruiting NCT07313410 Sponsor: The University of Texas at Arlington Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Peripheral Arterial Disease Trial, Recruiting

NCT07313410
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For participants with PAD (Cases – Part 1):

  • People aged 18 or older
  • People who are willing and able to give informed consent to participate
  • People who have been officially diagnosed with peripheral artery disease (PAD) by a doctor
  • People who are able to follow the study requirements throughout the trial

For participants with PAD (Cases – Part 2):

  • People who have already completed Part 1 of this trial

For comparison participants (Controls):

  • People who have no symptoms, history, or diagnosis of peripheral artery disease

Who may not be able to join:

For participants with PAD (Cases – Part 1):

  • People whose ankle-brachial index (a blood pressure measurement comparing the ankle and arm) falls above 0.9 or below 0.4 (confirm with trial site)
  • People whose artery disease is located only in the aorta or the large vessels in the pelvis area
  • People who have had unstable chest pain or a heart attack within the past 12 months
  • People with physical or joint/bone conditions that would prevent data from being collected
  • People who are unable to have an MRI scan, including those with a pacemaker, bone growth or fusion stimulators, a tissue expander, cochlear implants, a need for continuous oxygen therapy, or permanent jewellery that cannot be removed, those who are pregnant, or those unable to walk at least 10 feet

For participants with PAD (Cases – Part 2):

  • People who have had unstable chest pain or a heart attack within the past 12 months
  • People with physical or joint/bone conditions that would prevent data from being collected
  • People who are unable to have an MRI scan for any of the same reasons listed above under Part 1

For comparison participants (Controls):

  • People with any history of peripheral artery disease
  • People with known heart disease such as heart failure
  • People with a known lung condition (except mild asthma)
  • People who currently use tobacco products
  • People with physical or joint/bone conditions that would prevent data from being collected
  • People whose blood pressure measures above 150/90 mmHg at the screening visit
  • People who are unable to have an MRI scan for any of the same reasons listed above under Part 1

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 8175130383

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The University of Texas at Arlington
Registry
ClinicalTrials.gov
Start date
1 November 2025
Est. completion
31 December 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Perceived Quality of life; Ankle- Brachial Index; Walking ability; Functional performance; Steps taken; Oxygen level of leg muscles; Body composition; Leg Exercise MRI; Lower Leg Ischemia-Reperfusion; Leg muscle size and quality

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov